{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52028271",
    "licUnit": "1",
    "validDate": "2027-03-09 00:00:00.000",
    "issueDate": "2022-03-09 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA05202827104",
    "prodNameC": "寧挺達命乙磺酸鹽",
    "prodNameE": "Nintedanib Esylate",
    "indicationsName": [
        "特發性肺纖維化"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "44"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "mainCategory": "E",
    "drBaseId": "6C2B86C7-2BBC-4135-AB96-BAC3174A4D01",
    "subCategory": [],
    "ingredientsDesc": [
        "Nintedanib Esylate contains not less than 98.0 % and not more than 102.0 % of C31H33N5O4‧C2H6O3S, calculated on the anhydrous basis."
    ],
    "restraintItemsCode": [
        "02"
    ],
    "applicantName": "東譽興業股份有限公司",
    "applicantAddr": "台北市中山區南京東路２段２０６號８樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "26B61068-9E88-4480-83A6-A93E4F83B46F",
            "factoryCode": "1",
            "factoryName": "GLENMARK LIFE SCIENCES LIMITED",
            "factoryAddr": "Plot No.Z\/103\/I, SEZ Phase-II, Dahej, Taluka Vagra, Dist.Bharuch,392130, Gujarat, India",
            "factoryCompanyAddr": "",
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN0122300",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsName": "Nintedanib Esylate contains not less than 98.0 % and not more than 102.0 % of C31H33N5O4‧C2H6O3S, calculated on the anhydrous basis.",
            "ingredientsDesc": "Nintedanib Esylate contains not less than 98.0 % and not more than 102.0 % of C31H33N5O4‧C2H6O3S, calculated on the anhydrous basis.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EX09"
        }
    ],
    "licBaseId": "149102F0-A873-43FF-941B-900FA1CA9A3D"
}